• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CYSB2101011 重组人促红素注射液(CHO细胞) Human Erythropoietin Injection Biological Products Supplementary Application 2021-03-22 Beijing Four Rings Bio-Pharmaceutical Co Ltd view
CYSB2101007 重组人促红素注射液(CHO细胞) Human Erythropoietin Injection Biological Products Supplementary Application 2021-03-22 Beijing Four Rings Bio-Pharmaceutical Co Ltd view
CYSB2101010 重组人促红素注射液(CHO细胞) Human Erythropoietin Injection Biological Products Supplementary Application 2021-03-22 Beijing Four Rings Bio-Pharmaceutical Co Ltd view
CYSB2101006 重组人促红素注射液(CHO细胞) Human Erythropoietin Injection Biological Products Supplementary Application 2021-03-22 Beijing Four Rings Bio-Pharmaceutical Co Ltd view
CYSB2101014 重组人促红素注射液(CHO细胞) Human Erythropoietin Injection Biological Products Supplementary Application 2021-03-22 Beijing Four Rings Bio-Pharmaceutical Co Ltd view
CYSB2101009 重组人促红素注射液(CHO细胞) Human Erythropoietin Injection Biological Products Supplementary Application 2021-03-22 Beijing Four Rings Bio-Pharmaceutical Co Ltd view
CYSB2101015 重组人促红素注射液(CHO细胞) Human Erythropoietin Injection Biological Products Supplementary Application 2021-03-22 Beijing Four Rings Bio-Pharmaceutical Co Ltd view
CYSB2101013 重组人促红素注射液(CHO细胞) Human Erythropoietin Injection Biological Products Supplementary Application 2021-03-22 Beijing Four Rings Bio-Pharmaceutical Co Ltd view
CYSB2101008 重组人促红素注射液(CHO细胞) Human Erythropoietin Injection Biological Products Supplementary Application 2021-03-22 Beijing Four Rings Bio-Pharmaceutical Co Ltd view
CYSB2101012 重组人促红素注射液(CHO细胞) Human Erythropoietin Injection Biological Products Supplementary Application 2021-03-22 Beijing Four Rings Bio-Pharmaceutical Co Ltd view
X0300490 重组人白细胞介素-2 注射液 Recombinant Human Interleukin-2 Injection Biological Products(13) New Drug Application 2003-09-27 北京四环生物制药有限公司 Beijing Four Rings Bio-Pharmaceutical Co Ltd Certificate Issued 2004-02-09 view
CYSB1900240 重组人促红素注射液(CHO细胞) Human Erythropoietin Injection Biological Products Supplementary Application 2019-07-01 北京四环生物制药有限公司 Beijing Four Rings Bio-Pharmaceutical Co Ltd Certificate Issued 2019-08-27 view
CYSB1200090 重组人促红素注射液(CHO细胞) Human Erythropoietin Injection Biological Products Supplementary Application 2013-01-14 北京四环生物制药有限公司 Beijing Four Rings Bio-Pharmaceutical Co Ltd Certificate Issued 2014-05-16 view
CYSB1900262 重组人白介素-2注射液 Recombinant Human Interleukin-2 Injection Biological Products Supplementary Application 2019-07-12 北京四环生物制药有限公司 Beijing Four Rings Bio-Pharmaceutical Co Ltd Certificate Issued 2019-09-16 view
CYSB1900236 重组人促红素注射液(CHO细胞) Human Erythropoietin Injection Biological Products Supplementary Application 2019-07-01 北京四环生物制药有限公司 Beijing Four Rings Bio-Pharmaceutical Co Ltd Certificate Issued 2019-08-27 view
CYSB0600092 重组人促红素注射液 Human Erythropoietin Injection Biological Products Supplementary Application 2007-04-16 北京四环生物制药有限公司 Beijing Four Rings Bio-Pharmaceutical Co Ltd Certificate Issued 2008-04-18 view
CYSB1900244 重组人促红素注射液(CHO细胞) Human Erythropoietin Injection Biological Products Supplementary Application 2019-07-01 北京四环生物制药有限公司 Beijing Four Rings Bio-Pharmaceutical Co Ltd Certificate Issued 2019-08-27 view
CYSB1200294 重组人促红素注射液(CHO细胞) Human Erythropoietin Injection Biological Products Supplementary Application 2013-04-12 北京四环生物制药有限公司 Beijing Four Rings Bio-Pharmaceutical Co Ltd Certificate Issued 2013-12-06 view
CYSB1200092 重组人促红素注射液(CHO细胞) Human Erythropoietin Injection Biological Products Supplementary Application 2013-01-14 北京四环生物制药有限公司 Beijing Four Rings Bio-Pharmaceutical Co Ltd Certificate Issued 2014-05-16 view
CYSB1900261 重组人白介素-2注射液 Recombinant Human Interleukin-2 Injection Biological Products Supplementary Application 2019-07-12 北京四环生物制药有限公司 Beijing Four Rings Bio-Pharmaceutical Co Ltd Certificate Issued 2019-09-16 view